Anatomic pathology testing market outlook

According to the Technavio’s analyst, the global anatomic pathology testing market is anticipated to grow at a steady rate and will post a CAGR of more than 8% during the forecast period. The increasing use and efficiency of biomarkers in the diagnosis of various disease will drive the growth prospects of the global anatomic pathology testing market until the end of 2021. It has been observed that biomarkers are increasingly used in various clinical studies in the areas of proteomics, genomics, transcriptomics, and metabolomics to evaluate pharmacological, physiological, and disease processes.

At present, biomarkers are increasingly used for cancer diagnostics, and some of the common biomarkers used for cancer detection are keratins, vimentin, S100protein, CD45, CD3, CD20, CD30, TTF-1, CDX2, BRST-2, HMB-45, RCC, and HEPAR1. Consequently, the volume of biomarker analysis for various disease diagnosis processes will increase in the coming years, which will accelerate the rate of sales of tissue diagnostic products.

Get A Free Sample 

Anatomic pathology testing market forecast by geography

In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four year. One of the major factors responsible for the market’s growth in the region is the growing trend for an ePathology solution.

Anatomic pathology testing market opportunity for key vendors

The global anatomic pathology testing market is highly competitive and diversified due to the presence of a large number of regional and international vendors across the globe. It has been observed that these vendors are increasingly competing against each other based on factors such as aggressive pricing, product differentiation, capital support for product or technology up gradation, and distribution partnerships. Furthermore, to strengthen their position in the market, these vendors increasingly focus on the instrumentation of immunohistochemistry (IHC) and in situ hybridization (ISH) technologies.

Key vendors in the anatomic pathology testing market

• Abbott Diagnostics
• Agilent Technologies
• Danaher
• Roche Diagnostics
• Thermo Fisher Scientific

Anatomic pathology testing market worth by application

• Lymphoma
• Breast cancer
• Lung cancer
• Colorectal cancer
• Cervical cancer
• Prostate cancer

The lung cancer segment accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. One of the major factors responsible for the market segment’s growth is the growing advancements in lung cancer detection that has led to the discovery of lung cancer biomarkers —tyrosine kinase inhibitors.

Anatomic pathology testing market by end user

• Clinical diagnostic laboratories
• Hospitals
• Physicians' office laboratories

The clinical diagnostic laboratories segment accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. Some of the benefits associated with this market’s segment include low in-patient cost structure, direct-to-consumer (DTC) facility, and the integration of inpatient and outreach laboratories through electronic health records.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global anatomic pathology testing market?
• What are the key market trends impacting the growth of the global anatomic pathology testing market?
• What are the challenges to market growth?
• Who are the key vendors in the global anatomic pathology testing market?
• What are the market opportunities and threats faced by the vendors in the global anatomic pathology testing market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global anatomic pathology testing market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

• Global Clinical Reference Laboratory Services Market 2016-2020
• Global Genomics Biomarkers Market 2017-2021
• Global MRSA Testing Market 2017-2021
• Global Coagulation Testing Market 2017-2021